November 2017 in “JAMA internal medicine” This letter to the editor states that the titles of two recent pieces in JAMA Internal Medicine should have included "in Men.
July 2023 in “Dermatology and Therapy” This review analyzed the use of 5-alpha reductase inhibitors (5ARIs) for treating various dermatological conditions such as androgenetic alopecia, acne, and hirsutism, emphasizing their efficacy and safety profile.
January 2015 in “Current Opinion in Endocrinology, Diabetes and Obesity”
31 citations
,
January 1995 in “The American journal of medicine” This article reviews the role of 5α-reductase in cutaneous hyperandrogenism and the potential of 5α-reductase inhibitors and antiandrogens in treating conditions like hirsutism and male-pattern baldness, reporting no clinical results.
15 citations
,
March 1997 in “International Journal of Dermatology” This article discusses the potential use of 5α-reductase inhibitors in dermatology and reports no new clinical results; the authors suggest further exploration of their dermatological applications.